During the coronavirus disease 2019 (COVID‐19) pandemic, the urgency for updated
evidence to inform public health and clinical care placed systematic literature reviews …

Background: The global pandemic coronavirus disease 2019 (COVID-19) has become a
major public health problem and presents an unprecedented challenge. However, no …

Background: To date, there has been little agreement on what drug is the" best" drug for
treating severe COVID-19 patients. This study aimed to assess the efficacy and safety of …

Background: Several pharmacological interventions are now under investigation for the
treatment of Covid-19, and the evidence is evolving rapidly. Our aim is to assess the …

Background Numerous clinical trials and observational studies have investigated various
pharmacological agents as potential treatment for Coronavirus Disease 2019 (COVID-19) …

Background Navigating the rapidly growing body of scientific literature on the SARS-CoV-2
pandemic is challenging and ongoing critical appraisal of this output is essential. We aimed …

Introduction Up to now, numerous randomized controlled trials (RCTs) have examined
various drugs as possible treatments for Coronavirus Disease 2019 (COVID-19), but the …

Background: Coronavirus disease 2019 (COVID-19) has rapidly spread worldwide, but safe
and effective treatment options remain unavailable. Numerous systematic reviews of varying …

Background Navigating the rapidly growing body of scientific literature on the SARS-CoV-2
pandemic is challenging, and ongoing critical appraisal of this output is essential. We aimed …

This study aimed to assess the efficacy and safety of different medications available at
present for severe coronavirus disease 2019 (COVID‐19) infection. We searched databases …